Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 20;12(2):544.
doi: 10.3390/diagnostics12020544.

Factors Associated with Delirium in COVID-19 Patients and Their Outcome: A Single-Center Cohort Study

Annabella Di Giorgio  1 , Antonio Mirijello  2 , Clara De Gennaro  1 , Andrea Fontana  3 , Paolo Emilio Alboini  1 , Lucia Florio  1 , Vincenzo Inchingolo  1 , Michele Zarrelli  1 , Giuseppe Miscio  4 , Pamela Raggi  5 , Carmen Marciano  5 , Annibale Antonioni  6 , Salvatore De Cosmo  2 , Filippo Aucella  7 , Antonio Greco  8 , Massimo Carella  5 , Massimiliano Copetti  3 , Maurizio A Leone  1
Affiliations

Factors Associated with Delirium in COVID-19 Patients and Their Outcome: A Single-Center Cohort Study

Annabella Di Giorgio et al. Diagnostics (Basel). .

Abstract

Background: A significant proportion of patients with coronavirus disease 2019 (COVID-19) suffer from delirium during hospitalization. This single-center observational study investigates the occurrence of delirium, the associated risk factors and its impact on in-hospital mortality in an Italian cohort of COVID 19 inpatients.

Methods: Data were collected in the COVID units of a general medical hospital in the South of Italy. Socio-demographic, clinical and pharmacological features were collected. Diagnosis of delirium was based on a two-step approach according to 4AT criteria and DSM5 criteria. Outcomes were: dates of hospital discharge, Intensive Care Unit (ICU) admission, or death, whichever came first. Univariable and multivariable proportional hazards Cox regression models were estimated, and risks were reported as hazard ratios (HR) along with their 95% confidence intervals (95% CI).

Results: A total of 47/214 patients (22%) were diagnosed with delirium (21 hypoactive, 15 hyperactive, and 11 mixed). In the multivariable model, four independent variables were independently associated with the presence of delirium: dementia, followed by age at admission, C-reactive protein (CRP), and Glasgow Coma Scale. In turn, delirium was the strongest independent predictor of death/admission to ICU (composite outcome), followed by Charlson Index (not including dementia), CRP, and neutrophil-to-lymphocyte ratio. The probability of reaching the composite outcome was higher for patients with the hypoactive subtype than for those with the hyperactive subtype.

Conclusions: Delirium was the strongest predictor of poor outcome in COVID-19 patients, especially in the hypoactive subtype. Several clinical features and inflammatory markers were associated with the increased risk of its occurrence. The early recognition of these factors may help clinicians to select patients who would benefit from both non-pharmacological and pharmacological interventions in order to prevent delirium, and in turn, reduce the risk of admission to ICU or death.

Keywords: C-reactive protein; COVID-19; delirium; mortality; neutrophils-to lymphocyte ratio.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest, and that the funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curves according to presence/absence of delirium.
See this image and copyright information in PMC

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Arlington, VA, USA: 2013.
    1. Wilson J.E., Mart M.F., Cunningham C., Shehabi Y., Girard T.D., MacLullich A.M.J., Slooter A.J.C., Ely E.W. Delirium. Nat. Rev. Dis. Primers. 2020;6:90. doi: 10.1038/s41572-020-00223-4. Erratum in Nat. Rev. Dis. Primers 2020, 6, 94. - DOI - PMC - PubMed
    1. D’Ardes D., Carrarini C., Russo M., Dono F., Speranza R., Digiovanni A., Martinotti G., Di Iorio A., Onofrj M., Cipollone F., et al. Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization. Neurol. Sci. 2021;42:1527–1530. doi: 10.1007/s10072-020-04887-4. - DOI - PMC - PubMed
    1. Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with com- parison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611–627. doi: 10.1016/S2215-0366(20)30203-0. - DOI - PMC - PubMed
    1. Shao S.C., Lai C.C., Chen Y.H., Chen Y.C., Hung M.J., Liao S.C. Prevalence, incidence and mortality of delirium in patients with COVID-19: A systematic review and meta-analysis. Age Ageing. 2021;50:1445–1453. doi: 10.1093/ageing/afab103. - DOI - PMC - PubMed